表紙
市場調査レポート

頸動脈ステントの世界市場:2015年〜2019年

Global Carotid Stent Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 335127
出版日 ページ情報 英文 93 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
頸動脈ステントの世界市場:2015年〜2019年 Global Carotid Stent Market 2015-2019
出版日: 2015年07月08日 ページ情報: 英文 93 Pages
概要

世界の頸動脈ステント市場は、2014年〜2019年のCAGRで、13.17%の成長が見込まれています。

当レポートでは、世界の頸動脈ステント市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 頚動脈狭窄:概要

  • 背景
  • 頸動脈狭窄
  • 頸動脈狭窄の治療選択肢

第8章 頸動脈ステント留置術

第9章 世界の償還シナリオ

  • 米国の償還シナリオ
  • その他の主要国の償還シナリオ

第10章 地理区分

  • 世界の頚動脈ステント市場:地域別
  • 南北アメリカの頚動脈ステント市場
    • 市場規模と予測
  • 欧州・中東・アフリカの頚動脈ステント市場
    • 市場規模と予測
  • アジア太平洋地域の頚動脈ステント市場
    • 市場規模と予測

第11章 購入基準

第12章 市場成長促進要因

第13章 成長促進要因とその影響

第14章 市場の課題

第15章 成長促進要因と課題の影響

第16章 市場動向

第17章 動向とその影響

第18章 ベンダー情勢

  • 競合シナリオ
  • 主要ベンダー分析
  • その他の有力ベンダー

第19章 主要ベンダー分析

  • Abbott Laboratories
  • Boston Scientific
  • Cordis
  • Medtronic

第20章 関連レポート

図表

目次
Product Code: IRTNTR6466

About Carotid Stent

Carotid artery disease refers to the blockage or narrowing of carotid arteries due to plaque formation (Fibrous tissue, cholesterol, and calcium deposits. The carotid arteries are present in the neck and supply blood to the brain. Carotid artery stenting is a minimally invasive surgical procedure used to treat carotid artery disease. The technique involves the insertion of a slender metal-mesh tube (carotid stent) through a small incision. The carotid stent expands inside a carotid artery to increase blood flow in areas blocked by plaque. Globally, 90% of carotid surgeries are performed by vascular surgeons.

Technavio's analysts forecast the global carotid stent market to grow at a CAGR of 13.17% over the period 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the global carotid stent market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from sales of carotid stents.

Technavio's report, Global Carotid Stent Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global carotid stent market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbott Vascular
  • Boston Scientific
  • Cordis (Johnson & Johnson)
  • Medtronic

Other Prominent Vendors

  • ev3
  • Gore Medical
  • InspireMD
  • Optimed
  • Terumo

Market Driver

  • High Proportion of Elderly Population
  • For a full, detailed list, view our report

Market Challenge

  • Complications of Carotid Artery Stenting
  • For a full, detailed list, view our report

Market Trend

  • Rise in Number of Clinical Trials
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Carotid Artery Stenosis: An Overview

  • 07.1. Background
  • 07.2. Carotid Artery Stenosis
    • 07.2.1. Risk Factors for Carotid Artery Stenosis
    • 07.2.2. Symptoms of Carotid Artery Stenosis
  • 07.3. Treatment Options for Carotid Artery Stenosis
    • 07.3.1. Treatment Recommendation for Symptomatic Carotid Artery Stenosis
    • 07.3.2. Treatment Recommendation for Asymptomatic Carotid Artery Stenosis

08. Carotid Artery Stenting

09. Global Reimbursement Scenario

  • 09.1. Reimbursement Scenario in US
    • 09.1.1. Medicare Reimbursement Policy
    • 09.1.2. Private Insurance Policy
    • 09.1.3. ICD-9-CM Diagnosis Codes and Payments for Carotid Artery Procedures
  • 09.2. Reimbursement Scenario in Other Major Countries
    • 09.2.1. UK
    • 09.2.2. Germany
    • 09.2.3. Spain
    • 09.2.4. Italy
    • 09.2.5. France
    • 09.2.6. Japan

10. Geographical Segmentation

  • 10.1. Global Carotid Stent Market by Geography 2014-2019
  • 10.2. Carotid Stent Market in Americas
    • 10.2.1. Market Size and Forecast
  • 10.3. Carotid Stent Market in EMEA
    • 10.3.1. Market Size and Forecast
  • 10.4. Carotid Stent Market in APAC
    • 10.4.1. Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Major Vendor Analysis 2014
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Laboratories
    • 19.1.1. Key Facts
    • 19.1.2. Business Description
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Strategy
    • 19.1.5. Revenue by Business Segmentation
    • 19.1.6. Revenue Comparison 2011 and 2012
    • 19.1.7. Revenue by Geographical Segmentation
    • 19.1.8. Key Information
    • 19.1.9. SWOT Analysis
  • 19.2. Boston Scientific
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Key Products
    • 19.2.4. Key Products in Cardiovascular Segment
    • 19.2.5. Key Products in MedSurg Segment
    • 19.2.6. Key Products in Rhythm Management Segment
    • 19.2.7. Business Segmentation by Revenue 2013
    • 19.2.8. Business Segmentation by Revenue 2012 and 2013
    • 19.2.9. Geographical Segmentation by Revenue 2013
    • 19.2.10. Business Strategy
    • 19.2.11. Recent Developments
    • 19.2.12. SWOT Analysis
  • 19.3. Cordis
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Business Segmentation
    • 19.3.4. Business Strategy
    • 19.3.5. Recent Developments
    • 19.3.6. SWOT Analysis
  • 19.4. Medtronic
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Key Products
    • 19.4.4. Business Segmentation by Revenue 2014
    • 19.4.5. Cardiac and Vascular Group Segmentation by Revenue 2014
    • 19.4.6. Restorative Therapies Group Segmentation by Revenue 2014
    • 19.4.7. Diabetes Group Segmentation by Revenue 2014
    • 19.4.8. Business Segmentation by Revenue 2013 and 2014
    • 19.4.9. Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
    • 19.4.10. Restorative Therapies Group Segmentation by Revenue 2013 and 2014
    • 19.4.11. Diabetes Group Segmentation by Revenue 2013 and 2014
    • 19.4.12. Geographical Segmentation by Revenue 2014
    • 19.4.13. Business Strategy
    • 19.4.14. Key Developments
    • 19.4.15. SWOT Analysis

20. Other Reports in This Series

List Of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Carotid Stent Market 2014-2019 ($ millions)
  • Exhibit 3: Management of Carotid Artery Stenosis
  • Exhibit 4: Steps in Carotid Artery Stenting
  • Exhibit 5: Various Access Sites for Stenting
  • Exhibit 6: Global Carotid Stent Market by Geography 2014
  • Exhibit 7: Carotid Stent Market in Americas 2014-2019 ($ millions)
  • Exhibit 8: Carotid Stent Market in EMEA 2014-2019 ($ millions)
  • Exhibit 9: Carotid Stent Market in APAC 2014-2019 ($ millions)
  • Exhibit 10: Global Carotid Stent Market by Geography 2014-2019 ($ millions)
  • Exhibit 11: Global Carotid Stent Market by Geography 2014-2019
  • Exhibit 12: Major Drivers of Global Carotid Stent Market
  • Exhibit 13: Percentage of Elderly Aged Above 65 in Different Regions and Countries 2012 and 2050
  • Exhibit 14: Global Incidence of CAD with Age
  • Exhibit 15: Major Challenges in Global Carotid Stent Market
  • Exhibit 16: Major Trends in Global Carotid Stent Market
  • Exhibit 17: Abbott Laboratories: Key Takeaways
  • Exhibit 18: Boston Scientific: Key Takeaways
  • Exhibit 19: Cordis: Key Takeaways
  • Exhibit 20: Medtronic: Key Takeaways
  • Exhibit 21: Abbott Laboratories: Business Segmentation
  • Exhibit 22: Abbott Laboratories: Revenue by Business Segmentation 2012
  • Exhibit 23: Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 ($ millions)
  • Exhibit 24: Abbott Laboratories: Revenue by Geographical Segmentation 2012
  • Exhibit 25: Boston Scientific: Key Products in Cardiovascular Segment
  • Exhibit 26: Boston Scientific: Key Products in MedSurg Segment
  • Exhibit 27: Boston Scientific: Key Products in Rhythm Management Segment
  • Exhibit 28: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 29: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 30: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 31: Cordis: Business Segmentation 2013
  • Exhibit 32: Medtronic: Key Products
  • Exhibit 33: Medtronic: Business Segmentation by Revenue 2014
  • Exhibit 34: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
  • Exhibit 35: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
  • Exhibit 36: Medtronic: Diabetes Group Segmentation by Revenue 2014
  • Exhibit 37: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 38: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 39: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 40: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 41: Medtronic: Geographical Segmentation by Revenue 2014
Back to Top